What Does BPC-157 Dissolve In? Solvents Explained
Solubility behaviour is where compounds in this library differ most sharply from one another. For BPC-157, the determining factors are structural: synthetic pentadecapeptide (15 residues), acetate salt.
In plain English
It dissolves in plain bacteriostatic water without any tricks. Its structure is loose and open with no greasy section to resist water, which is why it goes into solution so readily. If a vial is not clearing, the cause is almost always a damaged powder cake — not the wrong liquid.
What BPC-157 actually is
BPC-157 is a short chain of fifteen amino acids originally identified in stomach fluid — an environment whose whole chemical job is to break proteins apart. It got attention precisely because it survived that. In research it is studied around how new blood vessels form and how repair signals travel through tissue.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
How BPC-157 behaves in solution
Freely water-soluble and among the most forgiving peptides in this catalogue to reconstitute. The high proline content (five of fifteen residues) gives an extended, largely unstructured conformation with no hydrophobic core to drive aggregation, so it dissolves without acidification, sonication, or warming. Solutions are clear and colourless — persistent cloudiness indicates a handling problem, not a solubility limit.
Commonly worked at 1–5 mg/mL; higher concentrations remain clear but offer no handling advantage.
Suitable solvents, in order
Structural basis
BPC-157 is synthetic pentadecapeptide (15 residues), acetate salt. BPC-157 is a 15-amino-acid sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) isolated from a larger protein found in human gastric juice. Its provenance is the reason for one of its most-cited laboratory properties: it was characterised as remaining intact in gastric-fluid conditions that rapidly hydrolyse most peptides.
What BPC-157 is studied for
Preclinical work has examined interactions with VEGFR2 signalling and vessel formation in tissue models.
The compound's gastric-juice provenance drove an early and substantial literature in GI mucosal research models.
Studies have investigated fibroblast behaviour and collagen organisation in tendon and ligament models.
A recurring theme in published work is modulation of the NO system in animal models.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More BPC-157 reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Solubility reference for other compounds
BPC-157 is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.